General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region Forums2 weeks after CEO Martin Shkreli announced he would lower the price of Daraprim, price is the same
It's been two weeks since Turing CEO Martin Shkreli announced he would scale back the price of his drug, and so far nothing has really changed.
The biotech leader came under fire last month for his 5,000% price hike of Daraprim, a drug that fights parasitic infections.
The drug, which rose from $13.50 to $750 seemingly overnight, left the biotech and pharmaceutical industries reeling, with corporations such as Valeant facing a lot of criticism for their similar price-hike moves.
In September, he told ABC News, Weve agreed to lower the price of Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit."
Read more: http://www.businessinsider.com/martin-shkreli-update-on-daraprim-price-2015-10
workinclasszero
(28,270 posts)lies?
I'm shocked, shocked I say! Just wait till Congress hears about this!
sub.theory
(652 posts)That we continue to allow profiteering at the expense of people's lives is madness. All (yes all) pharmaceuticals need to be placed under strict, government controlled price controls. Anyone who doesn't like it can immediately leave the pharmaceutical industry.
Ms. Toad
(34,066 posts)KT2000
(20,577 posts)Nothing. Media needs to keep up on this. If not them then it must be us.
mhatrw
(10,786 posts)djean111
(14,255 posts)That was all theater, folks. Sound bites. In fact, the only people who benefited are the ones who bought temporarily lower-priced stock in Pharma.
moondust
(19,976 posts)to become the world's first trillionaire. We don't really want to start punishing ambition and success, do we?
(Awaiting my call from Fox Business and CNBC...)